Skip to main content
. Author manuscript; available in PMC: 2016 May 2.
Published in final edited form as: J Neurotrauma. 2011 Dec 20;29(3):539–550. doi: 10.1089/neu.2011.1976

FIG. 3.

FIG. 3

Macrophage/microglia and neutrophils are seen in the injured cord at 42 days post-injury. (A) Representative photomicrographs of sections from the lesion epicenters of 1B7 and CD11d monoclonal antibody (mAb)-treated mice 42 days after spinal cord injury (SCI), immunostained with a Ly-6G antibody. There was no significant difference in the number of Ly-6G+ cells in CD11d mAb and 1B7 mAb-treated mice 42 days after SCI. (B) Representative photomicrographs of sections at the epicenter or 960 μm caudal or rostral to the epicenter from 1B7 and CD11d mAb-treated mice 42 days after SCI, immunostained with a Mac-1 antibody. Mac-1+ cells were generally stratified in appearance caudal and rostral to the lesion site. At the lesion site, Mac-1 cells were more round in appearance. (C) There was no significant difference in Mac-1 areas of immunoreactivity between 1B7 mAb-treated mice (open bars) compared to anti-CD11d-treated mice (gray bars; 6 mice/1B7 group and 6 mice/anti-CD11d group, two-way analysis of variance; scale bars in A and B = 100 μm and 50 μm for high-power insets).